HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Altaf Mohammed Selected Research
Altaf Mohammed Research Topics
Disease
41
Neoplasms (Cancer)
12/2021 - 01/2008
18
Carcinogenesis
08/2017 - 01/2010
16
Pancreatic Neoplasms (Pancreatic Cancer)
10/2019 - 01/2008
14
Adenocarcinoma
11/2021 - 09/2012
11
Colonic Neoplasms (Colon Cancer)
11/2021 - 01/2008
8
Carcinoma (Carcinomatosis)
11/2021 - 11/2010
8
Inflammation (Inflammations)
01/2021 - 12/2011
8
Carcinoma in Situ
11/2017 - 11/2010
7
Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 12/2012
7
Adenoma (Adenomas)
11/2021 - 09/2013
7
Polyps
01/2021 - 12/2011
4
Lung Neoplasms (Lung Cancer)
01/2021 - 09/2013
4
Adenocarcinoma of Lung
01/2021 - 09/2013
4
Transitional Cell Carcinoma
01/2016 - 08/2013
4
Intestinal Polyps
03/2014 - 02/2012
4
Aberrant Crypt Foci
01/2014 - 01/2008
3
Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 08/2013
3
Body Weight (Weight, Body)
01/2014 - 01/2008
2
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2021 - 03/2014
2
Hepatocellular Carcinoma (Hepatoma)
11/2020 - 01/2016
2
Fibrosis (Cirrhosis)
11/2020 - 04/2015
1
Adenomatous Polyps
01/2021
1
Intestinal Neoplasms (Intestinal Cancer)
01/2021
1
Liver Cirrhosis (Hepatic Cirrhosis)
11/2020
1
Precancerous Conditions
11/2020
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2019
Drug/Important Bio-Agent (IBA)
12
Proliferating Cell Nuclear Antigen (PCNA)
IBA
01/2021 - 12/2011
10
Pharmaceutical Preparations
IBA
01/2020 - 12/2013
9
Azoxymethane
IBA
11/2021 - 01/2008
7
Biomarkers (Surrogate Marker)
IBA
01/2021 - 09/2013
7
licofelone
IBA
08/2018 - 12/2011
6
Cyclin D1
IBA
01/2021 - 02/2012
5
Enzymes
IBA
03/2017 - 12/2011
4
Cytokines
IBA
01/2021 - 12/2011
4
Naproxen (Naprosyn)
FDA Link
Generic
01/2021 - 08/2018
4
Polyamines
IBA
11/2016 - 12/2014
4
Gefitinib (Iressa)
FDA Link
01/2016 - 11/2010
4
CP 31398
IBA
01/2015 - 05/2012
3
Vaccines
IBA
12/2021 - 01/2018
3
Carcinogens
IBA
11/2021 - 09/2013
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2021 - 01/2016
3
Caspase 3 (Caspase-3)
IBA
11/2019 - 05/2013
3
MicroRNAs (MicroRNA)
IBA
04/2019 - 03/2011
3
Eflornithine (Ornidyl)
FDA Link
11/2016 - 05/2013
3
Arachidonate 5-Lipoxygenase (5 Lipoxygenase)
IBA
10/2015 - 12/2011
3
Catenins
IBA
10/2015 - 05/2013
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2014 - 08/2013
3
Lipoxygenase (Lipoxygenase-1)
IBA
07/2014 - 12/2011
2
Acids
IBA
11/2021 - 01/2014
2
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
01/2021 - 01/2020
2
Sulindac (Copal)
FDA Link
Generic
01/2021 - 08/2018
2
Neoplasm Antigens (Tumor Antigens)
IBA
11/2020 - 01/2018
2
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2020 - 12/2013
2
Metformin (Glucophage)
FDA Link
Generic
01/2020 - 12/2013
2
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
11/2019 - 08/2018
2
Celecoxib (Celebrex)
FDA Link
08/2018 - 12/2011
2
Anti-Inflammatory Agents (Anti-Inflammatories)
IBA
08/2018 - 07/2014
2
DNA (Deoxyribonucleic Acid)
IBA
08/2017 - 05/2012
2
Biological Products
IBA
08/2017 - 04/2015
2
Mucins
IBA
03/2017 - 01/2016
2
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase)
IBA
03/2017 - 01/2016
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
11/2016 - 10/2012
2
Sirolimus (Rapamycin)
FDA Link
01/2016 - 12/2015
2
TOR Serine-Threonine Kinases
IBA
12/2015 - 12/2013
2
4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanone
IBA
12/2015 - 09/2013
2
ErbB Receptors (EGF Receptor)
IBA
10/2015 - 11/2010
2
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
10/2015 - 02/2012
2
Raloxifene Hydrochloride (Evista)
FDA Link
03/2014 - 12/2013
2
Estrogen Receptors
IBA
03/2014 - 12/2013
2
Estrogens (Estrogen)
FDA Link
03/2014 - 12/2013
2
Bexarotene (LGD1069)
FDA Link
12/2013 - 02/2012
2
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
08/2013 - 01/2008
2
Atorvastatin (Lipitor)
FDA Link
05/2013 - 10/2012
2
Omega-3 Fatty Acids (Omega 3 Fatty Acids)
IBA
12/2012 - 01/2008
2
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
IBA
12/2012 - 12/2011
2
Transcription Factors (Transcription Factor)
IBA
05/2012 - 03/2011
1
Immunomodulating Agents
IBA
12/2021
1
Interleukin-6 (Interleukin 6)
IBA
11/2021
1
Proton Pump Inhibitors
IBA
11/2021
1
Omeprazole (Prilosec)
FDA Link
Generic
11/2021
1
Matrix Metalloproteinase 7 (Matrilysin)
IBA
01/2021
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2021
1
Cancer Vaccines
IBA
11/2020
1
Immune Checkpoint Inhibitors
IBA
11/2020
1
Alendronate (Alendronate Sodium)
FDA Link
Generic
01/2020
1
hydroxide ion
IBA
01/2020
1
Drug Combinations
IBA
01/2020
1
Diphosphonates (Bisphosphonates)
IBA
01/2020
1
Zoledronic Acid (Zometa)
FDA Link
01/2020
1
Dinoprostone (PGE2)
FDA Link
11/2019
1
Tumor Biomarkers (Tumor Markers)
IBA
11/2019
1
Gastrins
IBA
10/2019
1
Cholecystokinin B Receptor
IBA
10/2019
1
YF 476
IBA
10/2019
1
4- bromo- N- (1- (2,4- difluoro- phenyl)ethyl)- 2- (quinoxaline- 5- sulfonylamino)benzamide
IBA
10/2019
1
Glucocorticoids
IBA
04/2019
Therapy/Procedure
16
Chemoprevention
03/2021 - 01/2008
2
Therapeutics
11/2020 - 01/2014
1
Colectomy
01/2021
1
Immunotherapy
11/2020